|D019954||Neurobehavioral Manifestations NIH||1.00|
There is one clinical trial.
The purpose of this study is to evaluate the health related benefits of a superfoods nutrition supplement on health related quality of life.
Description: The PSQI is a validated, self reporting instrument assessing sleep. Possible scores range from 0 to 21 with higher scores indicating lower quality sleep. The instrument contains 19 items.Measure: Change from baseline in sleep quality on Pittsburgh Sleep Quality Index (PSQI) on Day 60 Time: Baseline and day 60
Description: The PHQ is a validated, self reporting instrument assessing general wellbeing through sleep, respiratory health, headache, and gastrointestinal symptoms. Possible scores on each item range from 1 to 7 with higher scores indicating greater frequency of symptoms. The instrument contains 14 items.Measure: Change from baseline in general wellbeing on the Physical Health Questionnaire (PHQ) on Day 60 Time: Baseline and day 60
Description: The SRMCA is a validated, self reporting instrument assessing cognitive wellbeing. Possible scores range from 0 to 27 with higher scores indicating greater cognitive wellbeing. The instrument contains 44 items.Measure: Change from baseline in cognitive wellness on the Self Report Measure of Cognitive Abilities (SRMCA) on Day 60 Time: Baseline and day 60
Description: The Jackson Symptom Score is a validated, self reporting instrument which contains 8 cold and flu symptoms. Scores range from 0 (no symptoms) to 8 (every one of the listed symptoms.)Measure: Number of days with any cold symptoms as defined by the Jackson Symptom Score on day 60. Time: Day 60
Description: The PSS is a validated, self reporting instrument assessing perceived stress. Possible scores range from 0 to 40 with higher scores indicating higher stress levels. The instrument contains ten items.Measure: Change from baseline in stress on the Perceived Stress Scale (PSS) on Day 60 Time: Baseline and Day 60
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports